Demo Data from VLDB 2026 / reviewers in the wild / expert
Jenna C. Fromer
dblp:331/3869
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2025
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Artificial intelligence
1 paper |
Generative modeling · 100% | |
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Machine learning › Generative modeling
diffusion model |
0.9 | 1 | 2025 | ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design · ICLR 2025 |
Machine learning › Generative modeling › diffusion model › geometric diffusion model
equivariant diffusion model |
0.9 | 1 | 2025 | ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design · ICLR 2025 |
Bioinformatics and computational biology › drug discovery
drug design |
0.9 | 1 | 2025 | ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design · ICLR 2025 |
Methods — techniques the papers use, named apart from their topics
similarity scoring · 1.7SE(3)-equivariant diffusion · 1.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug designabstractEngineering molecules to exhibit precise 3D intermolecular interactions with their environment forms the basis of chemical design. In ligand-based drug design, bioisosteric analogues of known bioactive hits are often identified by virtually screening chemical libraries with shape, electrostatic, and pharmacophore similarity scoring functions. We instead hypothesize that a generative model which learns the joint distribution over 3D molecular structures and their interaction profiles may facilitate 3D interaction-aware chemical design. We specifically design ShEPhERD, an SE(3)-equivariant diffusion model which jointly diffuses/denoises 3D molecular graphs and representations of their shapes, electrostatic potential surfaces, and (directional) pharmacophores to/from Gaussian noise. Inspired by traditional ligand discovery, we compose 3D similarity scoring functions to assess ShEPhERD’s ability to conditionally generate novel molecules with desired interaction profiles. We demonstrate ShEPhERD’s potential for impact via exemplary drug design tasks including natural product ligand hopping, protein-blind bioactive hit diversification, and bioisosteric fragment merging. Keir Adams, Kento Abeywardane, Jenna C. Fromer, Connor W. Coley |
ICLR | 3 |